Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
to provide fact-checked information and guidance from those who understand your struggles
Biol Pharm Bull 41:10061013 Miroczuk-Chodakowska I, Witkowska AM, Zujko ME (2018) Endogenous non-enzymatic antioxidants in the human body
In terms of geography, the North America region dominated the total market for GLP-1 receptor agonists, owing increasing prevalence of diabetes and obesity, premium-priced GLP-1 drugs, and strong pipeline of potential candidates in the developed countries
Lifestyle interventions (including diet, exercise and behavioural changes) are the cornerstone of obesity management with diverse benefits, but even the most intensive lifestyle interventions result in up to 10% mean weight loss (WL) and weight maintenance remains a challenge, as 80% of WL is expected to be regained over the next 5 years [4, 5]
